EP
AUTL
Eversept Partners’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
610,231
+266,284
| +77% | +$607K | 0.13% | 57 |
|
|
2025
Q1 | $533K | Buy |
343,947
+245,052
| +248% | +$380K | 0.05% | 54 |
|
|
2024
Q4 | $232K | Sell |
98,895
-307,663
| -76% | -$723K | 0.02% | 62 |
|
|
2024
Q3 | $1.48M | Sell |
406,558
-204,344
| -33% | -$742K | 0.1% | 59 |
|
|
2024
Q2 | $2.13M | Buy |
+610,902
| New | +$2.13M | 0.15% | 62 |
|
|
2022
Q2 | – | Sell |
-371,540
| Closed | -$1.55M | – | 71 |
|
|
2022
Q1 | $1.55M | Sell |
371,540
-30,000
| -7% | -$125K | 0.12% | 58 |
|
|
2021
Q4 | $2.08M | Buy |
401,540
+3,466
| +0.9% | +$18K | 0.13% | 66 |
|
|
2021
Q3 | $2.61M | Sell |
398,074
-75,000
| -16% | -$491K | 0.18% | 57 |
|
|
2021
Q2 | $3.14M | Buy |
+473,074
| New | +$3.14M | 0.21% | 45 |
|
|
2021
Q1 | – | Sell |
-154,981
| Closed | -$1.39M | – | 79 |
|
|
2020
Q4 | $1.39M | Buy |
+154,981
| New | +$1.39M | 0.16% | 45 |
|
|
2020
Q3 | – | Sell |
-258,360
| Closed | -$4.14M | – | 50 |
|
|
2020
Q2 | $4.14M | Buy |
258,360
+48,347
| +23% | +$775K | 0.57% | 29 |
|
|
2020
Q1 | $1.26M | Buy |
+210,013
| New | +$1.26M | 0.31% | 34 |
|